Mutations May Cause Prostate Cancer Patients to Become Resistant to BET Inhibitors, Study Says
News
Mutations in the SPOP gene in prostate cancer are a reason patients often develop resistance to a class of treatment known as BET inhibitors, Mayo Clinic researchers report. This finding is in the ... Read more